| Makale Türü | Özgün Makale |
| Makale Alt Türü | SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale |
| Dergi Adı | Cytokine |
| Dergi ISSN | 1043-4666 Wos Dergi Scopus Dergi |
| Dergi Tarandığı Indeksler | SCI-Expanded |
| Dergi Grubu | Q2 |
| Makale Dili | Türkçe |
| Basım Tarihi | 09-2024 |
| Cilt No | 181 |
| Sayı | 1 |
| DOI Numarası | 10.1016/j.cyto.2024.156683 |
| Makale Linki | https://doi.org/10.1016/j.cyto.2024.156683 |
| Özet |
| This study was designed to evaluate serum LC3-II, BCL-2, IL-1β, TGF-β1, and podocin levels in. type 2 diabetes (T2DM) patients with renal dysfunction. 176 Turkish subjects were enrolled, of whom 26 were healthy, and 150 had T2DM. were classified according to albumin urea ratio: 88 patients had macroalbuminuria, 20. patients had microalbuminuria, and 42 had normoalbuminuria. T2DM patients were also. classified into three groups according to proteinuria and eGFR stages. Increased serum LC3-II levels in patients with T2DM with increased urinary albumin. extraction and impaired renal functions. There was a strong relationship between serum. LC3-II levels and serum BCL-2, IL-1β, TGF-β1, and Podocin levels. The efficiency of LC3- II as a diagnostic biomarker in the differential diagnosis of DM patients with. macroproteinuria from DM patients with normoproteinuria was 75.4%. It was thought that increased serum LC3-II levels in T2DM patients with impaired renal. functions may cause renal podocyte damage. In these patients, serum LC3-II levels can be. evaluated as a new biomarker to follow the development of renal damage. |
| Anahtar Kelimeler |
| Autophagy | BCL-2 | DKD | LC3-II | Podocin | Proteinuria |
| Dergi Adı | CYTOKINE |
| Yayıncı | Academic Press |
| Açık Erişim | Hayır |
| ISSN | 1043-4666 |
| E-ISSN | 1096-0023 |
| CiteScore | 7,6 |
| SJR | 0,970 |
| SNIP | 0,792 |